Cargando…

Iron-mediated aggregation and toxicity in a novel neuronal cell culture model with inducible alpha-synuclein expression

Parkinson’s disease (PD) represents an increasing problem in society. The oligomerization of alpha-synuclein (αSyn) is a suggested key event in its pathogenesis, yet the pathological modes of action remain to be fully elucidated. To identify potential disease-modifying therapeutics and to study αSyn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartels, Martin, Weckbecker, Daniel, Kuhn, Peer-Hendrik, Ryazanov, Sergey, Leonov, Andrei, Griesinger, Christian, Lichtenthaler, Stefan F., Bötzel, Kai, Giese, Armin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591385/ https://www.ncbi.nlm.nih.gov/pubmed/31235814 http://dx.doi.org/10.1038/s41598-019-45298-6

Ejemplares similares

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
por: Heras‐Garvin, Antonio, et al.
Publicado: (2018)

[(11)C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates
por: Kuebler, Laura, et al.
Publicado: (2020)

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
por: Wegrzynowicz, Michal, et al.
Publicado: (2019)

The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
por: Levin, Johannes, et al.
Publicado: (2014)

(11)C Radiolabeling of anle253b: a Putative PET Tracer for Parkinson's Disease That Binds to α‐Synuclein Fibrils in vitro and Crosses the Blood‐Brain Barrier
por: Maurer, Andreas, et al.
Publicado: (2020)

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)

Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
por: Wagner, Jens, et al.
Publicado: (2015)

The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
por: Antonschmidt, Leif, et al.
Publicado: (2022)

Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2016)

The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers
por: Saravanan, Manikam S., et al.
Publicado: (2019)

Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuIC
por: Ruf, Viktoria C., et al.
Publicado: (2020)

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
por: Levin, Johannes, et al.
Publicado: (2022)

SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine
por: Zhu, Lin-nan, et al.
Publicado: (2018)

Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
por: Angelova, Plamena R., et al.
Publicado: (2020)

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
por: Qiao, Liyan, et al.
Publicado: (2008)

Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity
por: Xiang, Wei, et al.
Publicado: (2015)

Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by α-Synuclein Oligomers in Lipid Membranes
por: Schmidt, Felix, et al.
Publicado: (2012)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
por: Miraglia, Fabiana, et al.
Publicado: (2020)

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
por: Cullen, Valerie, et al.
Publicado: (2009)

Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage
por: Rosado-Ramos, Rita, et al.
Publicado: (2023)

Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs
por: Latawiec, Diane, et al.
Publicado: (2010)

Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation
por: Torpey, James H., et al.
Publicado: (2020)

Aggregation of alpha-synuclein in enteric neurons does not impact function in vitro
por: Bindas, Adam J., et al.
Publicado: (2022)

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
por: Underwood, Rachel, et al.
Publicado: (2021)

Sumoylation inhibits α-synuclein aggregation and toxicity
por: Krumova, Petranka, et al.
Publicado: (2011)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

Subcellular localization of alpha-synuclein aggregates and their interaction with membranes
por: Miraglia, Fabiana, et al.
Publicado: (2018)

Alpha-synuclein fragments trigger distinct aggregation pathways
por: Chakroun, Tasnim, et al.
Publicado: (2020)

Small Molecule Fisetin Modulates Alpha–Synuclein Aggregation
por: Rosado-Ramos, Rita, et al.
Publicado: (2021)

Nanoparticles With Affinity for α-Synuclein Sequester α-Synuclein to Form Toxic Aggregates in Neurons With Endolysosomal Impairment
por: Jiang, Peizhou, et al.
Publicado: (2021)

Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation
por: Carboni, Eleonora, et al.
Publicado: (2017)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Kelly, Rachel, et al.
Publicado: (2021)

Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein
por: Xu, Ming-ming, et al.
Publicado: (2019)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
por: Köppen, Janett, et al.
Publicado: (2020)

Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates
por: Elfarrash, Sara, et al.
Publicado: (2019)

Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue
por: Stojkovska, Iva, et al.
Publicado: (2021)

Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex
por: Blumenstock, Sonja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_au5m8q3qe6a0s2o33m3hr63kq4